Authors:
THOUGAARD AV
HOGDALL CK
KJAER SK
BLAAKAER J
JALIASHVILI I
CHRISTIANSEN M
Citation: Av. Thougaard et al., DETERMINATION OF SERUM TETRANECTIN - TECHNICAL AND CLINICAL-EVALUATION OF 3 SANDWICH IMMUNOASSAYS, Clinica chimica acta, 276(1), 1998, pp. 19-34
Authors:
HOGDALL CK
CHRISTIANSEN M
CHRISTENSEN L
YAZOVA AK
KOCH C
CLEMMENSEN I
NORGAARDPEDERSEN B
Citation: Ck. Hogdall et al., MONOCLONAL-ANTIBODIES AGAINST HUMAN TETRANECTIN, EPITOPE CHARACTERIZATION AND USE IN IMMUNOHISTOCHEMISTRY, Clinica chimica acta, 258(2), 1997, pp. 159-177
Citation: J. Blaakaer et al., IMMUNOREACTIVE INHIBIN CONCENTRATION IN BLOOD TESTED UNDER VARIABLE SAMPLING CONDITIONS, Journal of steroid biochemistry and molecular biology, 58(3), 1996, pp. 325-328
Authors:
HOGDALL CK
HOGDALL EVS
HORDING U
TOFTAGERLARSEN K
ARENDS J
NORGAARDPEDERSEN B
CLEMMENSEN I
Citation: Ck. Hogdall et al., USE OF TETRANECTIN, CA-125 AND CASA TO PREDICT RESIDUAL TUMOR AND SURVIVAL AT 2ND-LOOK AND 3RD-LOOK OPERATIONS FOR OVARIAN-CANCER, Acta oncologica, 35(1), 1996, pp. 63-69
Authors:
BLAAKAER J
HOGDALL CK
MICIC S
TOFTAGERLARSEN K
HORDING U
BENNETT P
BOCK J
Citation: J. Blaakaer et al., OVARIAN-CARCINOMA SERUM MARKERS AND OVARIAN-STEROID ACTIVITY - IS THERE A LINK IN OVARIAN-CANCER - A CORRELATION OF INHIBIN, TETRANECTIN AND CA-125 TO OVARIAN ACTIVITY AND THE GONADOTROPIN-LEVELS, European journal of obstetrics, gynecology, and reproductive biology, 59(1), 1995, pp. 53-56
Authors:
HOGDALL CK
MOGENSEN O
TABOR A
MOGENSEN B
JAKOBSEN AKM
NORGAARDPEDERSEN B
LARSEN SO
CLEMMENSEN I
Citation: Ck. Hogdall et al., THE ROLE OF SERUM TETRANECTIN, CA-125, AND A COMBINED INDEX AS TUMOR-MARKERS IN WOMEN WITH PELVIC TUMORS, Gynecologic oncology, 56(1), 1995, pp. 22-28
Citation: M. Christiansen et al., ALPHA-FETOPROTEIN AND THE ACUTE-PHASE RESPONSE - A STUDY USING ACUTE PELVIC INFLAMMATORY DISEASE AS A MODEL SYSTEM, Clinica chimica acta, 235(1), 1995, pp. 71-79
Citation: Ck. Hogdall et al., SERUM TETRANECTIN IN PATIENTS WITH ACUTE PELVIC INFLAMMATORY DISEASE (PID) - CORRELATION TO CLINICAL AND LABORATORY FINDINGS, Acta obstetricia et gynecologica Scandinavica, 74(3), 1995, pp. 203-207
Authors:
HOGDALL CK
HORDING U
NORGAARDPEDERSEN B
TOFTAGERLARSEN K
CLEMMENSEN I
Citation: Ck. Hogdall et al., SERUM TETRANECTIN AND CA-125 USED TO MONITOR THE COURSE OF TREATMENT IN OVARIAN-CANCER PATIENTS, European journal of obstetrics, gynecology, and reproductive biology, 57(3), 1994, pp. 175-178
Authors:
NORGAARDPEDERSEN B
ALFTHAN H
ARENDS J
HOGDALL CK
LARSEN SO
STENMAN UH
SALONEN R
Citation: B. Norgaardpedersen et al., A NEW SIMPLE AND RAPID DUAL ASSAY FOR AFP AND FREE BETA-HCG IN SCREENING FOR DOWN-SYNDROME, Clinical genetics, 45(1), 1994, pp. 1-4
Authors:
BLAAKAER J
HOGDALL CK
HORDING U
BENNETT P
TOFTAGERLARSEN K
DAUGAARD S
BOCK J
Citation: J. Blaakaer et al., HORMONAL FACTORS AND PROGNOSIS IN EPITHELIAL OVARIAN-CANCER - A MULTIVARIATE-ANALYSIS, European journal of obstetrics, gynecology, and reproductive biology, 51(1), 1993, pp. 21-27
Authors:
HOGDALL CK
SOLETORMOS G
NIELSEN D
NORGAARDPEDERSEN B
DOMBERNOWSKY P
CLEMMENSEN I
Citation: Ck. Hogdall et al., PROGNOSTIC VALUE OF SERUM TETRANECTIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Acta oncologica, 32(6), 1993, pp. 631-636
Authors:
HOGDALL CK
HOGDALL EVS
HORDING U
CLEMMENSEN I
NORGAARDPEDERSEN B
TOFTAGERLARSEN K
Citation: Ck. Hogdall et al., PREOPERATIVE PLASMA TETRANECTIN AS A PROGNOSTIC MARKER IN OVARIAN-CANCER PATIENTS, Scandinavian journal of clinical & laboratory investigation, 53(7), 1993, pp. 741-746
Citation: Ck. Hogdall et al., THE PROGNOSTIC VALUE OF TETRANECTIN IMMUNOREACTIVITY AND PLASMA TETRANECTIN IN PATIENTS WITH OVARIAN-CANCER, Cancer, 72(8), 1993, pp. 2415-2422